Found 2 clinical trials
A Phase 2 Study to Evaluate the Safety, PK, and Exploratory PD of Tildacerfont in Children With CAH
An investigation of the safety of Tildacerfont in pediatric subjects with CAH.
21-ohd
- 0 views
- 22 Jul, 2022
- 4 locations
![A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])](/media/imagery/286630.svg)
A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])
This pre-screening study is designed to determine potential eligibility of adults with classic CAH due to 21-hydroxylase deficiency (21-OHD) for participation in the CAH-301 [NCT04783181] gene
classic congenital adrenal hyperplasia
deficiency
21-ohd
- 0 views
- 10 Mar, 2022
- 1 location